Schneeweiss, A. (2016). Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: An exploratory analysis of the TRYPHAENA study. BioMed Central.
Chicago-Zitierstil (17. Ausg.)Schneeweiss, Andreas. Evaluating the Predictive Value of Biomarkers for Efficacy Outcomes in Response to Pertuzumab- and Trastuzumab-based Therapy: An Exploratory Analysis of the TRYPHAENA Study. London: BioMed Central, 2016.
MLA-Zitierstil (9. Ausg.)Schneeweiss, Andreas. Evaluating the Predictive Value of Biomarkers for Efficacy Outcomes in Response to Pertuzumab- and Trastuzumab-based Therapy: An Exploratory Analysis of the TRYPHAENA Study. BioMed Central, 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.